2025-522930-29-00RecruitingPhase 1
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 29 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 22 Aug 2025
- Start date
- 1 Oct 2026
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization Inc.
- EU CT number
- 2025-522930-29-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 72
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.